mRNA |
Vinblastine |
GDSC1000 |
pan-cancer |
AAC |
0.049 |
0.1 |
mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
0.042 |
0.1 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
0.047 |
0.1 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.1 |
mRNA |
GW843682X |
GDSC1000 |
pan-cancer |
AAC |
-0.073 |
0.1 |
mRNA |
SJ-172550 |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.1 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.2 |
mRNA |
isoliquiritigenin |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.2 |
mRNA |
TAE684 |
CCLE |
pan-cancer |
AAC |
-0.062 |
0.2 |